# Phase 1 Study of PF-08046033 in Advanced Solid Tumors

> **NCT07519655** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 250 (estimated)

## Conditions studied

- Non-Small-Cell Lung
- Esophageal Cancer
- Cutaneous Melanoma

## Interventions

- **DRUG:** PF-08046033

## Key facts

- **NCT ID:** NCT07519655
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-08
- **Primary completion:** 2028-07-14
- **Final completion:** 2029-07-14
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07519655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07519655, "Phase 1 Study of PF-08046033 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07519655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*